Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
344
-
Total 13F shares, excl. options
-
37.8M
-
Shares change
-
+888K
-
Total reported value, excl. options
-
$3.95B
-
Value change
-
+$74.1M
-
Put/Call ratio
-
1.02
-
Number of buys
-
203
-
Number of sells
-
-146
-
Price
-
$104.39
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2025
430 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 344 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.8M shares
of 48.9M outstanding shares and own 77.34% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.95M shares), BlackRock, Inc. (3.83M shares), BVF INC/IL (1.69M shares), RTW INVESTMENTS, LP (1.52M shares), MACQUARIE GROUP LTD (1.14M shares), GEODE CAPITAL MANAGEMENT, LLC (989K shares), FMR LLC (977K shares), STATE STREET CORP (959K shares), Fairmount Funds Management LLC (815K shares), and Deep Track Capital, LP (801K shares).
This table shows the top 344 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.